CompletedPhase 4

Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease

United States33 participantsStarted 2025-11-01

Plain-language summary

The primary objective of this study is to show that consistent use of Systane PRO over a 30 period will significantly improve the signs and symptoms of Dry Eye Disease and decrease patients' ocular surface disease index score for patients diagnosed with mild-moderate (DED).

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 and older with mild-moderate DED (as determined by an OSDI score between 13-22). Exclusion Criteria: * Patients unwilling to discontinue all concomitant ophthalmic medications and dry eye therapies for the duration of the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This trial studied Systane PRO for mild to moderate dry eye disease — where does my current dry eye severity fall on that scale, and would a product like this even be appropriate for my situation?
2The trial measured changes in the OSDI symptom score over 30 days — is a one-month timeframe long enough to know whether an eye drop is actually working for someone with my type of dry eye?
3Since this was a Phase 4 trial, meaning Systane PRO is already approved and on the market, does that change your recommendation about whether I should try it now versus waiting to see the published results from this study?
4The trial has already completed — have you seen any data or findings from it yet, and do the results influence whether you'd suggest this product over other lubricating eye drops I might already be using?
5Are there standard prescription treatments for dry eye disease that you think I should consider before trying an over-the-counter product like the one studied in this trial?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Ocular Surface Disease Index (OSDI) Score From Baseline to Day 30

Timeframe: From enrollment to the end of participation at 28 days

Trial details

NCT IDNCT07639034

SponsorGordon Schanzlin New Vision

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-01

View on ClinicalTrials.gov More Dry Eye Disease (DED) trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.